Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Taihangia rupestris: UPLC-MS/MS and Bioactivity
2026-09-03
This 2026 RSC Advances study combines UPLC-MS/MS profiling, complementary antioxidant tests, α-glucosidase inhibition, activity-guided screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest chemical and functional profile, supporting conservation-oriented cultivation while identifying flavonoids and phenolics as priorities for further natural-product research.
-
GS-441524: Designing Matrix-Aware Antiviral Assays
2026-09-03
GS-441524 research is most informative when parent compound, released nucleoside, and downstream active metabolite are measured together. This article develops a matrix-aware assay strategy from recent LC–MS/MS evidence, with practical guidance for antiviral and pharmacokinetic studies.
-
NSP15 Screening Identifies Thymopentin and Oleuropein
2026-09-02
The 2021 reference study used structure-based virtual screening and molecular dynamics to prioritize natural products against the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein formed the most favorable and dynamically stable computational complexes, but biochemical and cellular validation remains necessary before interpreting them as antiviral inhibitors.
-
IDH2 Reprogramming Drives CRC Through HIF-1α
2026-09-02
The reference study identifies mitochondrial IDH2 as a metabolic driver of colorectal cancer progression, linking reductive TCA cycle activity to ATP production, glycolysis, and HIF-1α signaling. Its combined genetic, pharmacological, cellular, and in vivo evidence suggests that IDH2-dependent α-ketoglutarate handling is a potential metabolic vulnerability, while also defining experiments needed to separate energy failure from direct control of HIF-1α turnover.
-
Aβ42 Fibrils Activate Microglial Phagocytosis
2026-09-01
Kopec and Carroll showed that fibrillar Amyloid β-Peptide (1-42) stimulates murine microglial phagocytosis in a time- and dose-dependent manner. Their multi-cargo flow-cytometry design linked Aβ42 aggregation state, persistence after peptide removal, and proteoglycan-dependent regulation to a broader model of amyloid-driven innate immune activation.
-
Otilonium Bromide: Applied Research Workflows
2026-09-01
Otilonium Bromide provides a practical antimuscarinic perturbation tool for cholinergic signaling, smooth muscle contractility, and receptor-mediated cellular assays. This workflow-focused guide covers stock preparation, controls, concentration planning, troubleshooting, and responsible translation of structure-based screening concepts.
-
Abiraterone Acetate in 3D Prostate Models
2026-08-31
Build more informative prostate cancer research assays by pairing CYP17 inhibition with patient-derived three-dimensional spheroids. This workflow emphasizes compound identity, exposure control, orthogonal readouts, and troubleshooting when organ-confined models show limited response.
-
Superoxide Dismutase Activity Assay Kit
2026-08-31
The Superoxide Dismutase (SOD) Activity Assay Kit K2035 provides a colorimetric way to quantify functional SOD activity in biological fluids through inhibition of WST-1 formazan formation. It is intended for research assays and oxidative stress workflows, not for diagnosis, clinical decisions, or direct measurement of every reactive oxygen species.
-
TAM EV miR-660 Drives Breast Cancer Metastasis
2026-08-30
The reference study identifies a macrophage-to-tumor signaling route in which extracellular vesicle-enclosed miR-660 suppresses KLHL21 and activates the IKKβ/NF-κB p65 axis, thereby enhancing breast cancer invasion and metastasis. Its combination of patient samples, cell perturbation, extracellular vesicle transfer, and mouse modeling provides a mechanistic framework for studying tumor microenvironment-driven progression.
-
From JNK Signaling to Actionable Apoptosis Data
2026-08-29
A translational framework for using Annexin V-FITC/PI apoptosis profiling to connect JNK-dependent hepatoprotection with measurable cell-state outcomes in hepatic ischemia-reperfusion research.
-
BGJ398: FGFR Signaling in Cancer and Development
2026-08-28
BGJ398 (NVP-BGJ398) is a selective FGFR1/2/3 inhibitor with applications spanning oncology research and developmental biology. This article explains how the 2025 guinea pig–mouse study reshapes assay design, target interpretation, and translational use of FGFR inhibition.
-
BMS 599626 Dihydrochloride: Assay Strategy
2026-08-28
BMS 599626 dihydrochloride is an EGFR and ErbB2 inhibitor suited to mechanistic studies of receptor phosphorylation, HER1/HER2 signaling, and cancer cell proliferation inhibition. This assay-first guide also explains how machine-learning senolytic research can inform compound prioritization without overextending the available evidence.
-
(-)-Norepinephrine (+)-bitartrate Workflow
2026-08-27
Build reproducible adrenergic assays, hemodynamic screens, and cardiomyopathy workflows with a light-sensitive catecholamine salt designed for controlled exposure. This guide connects receptor-level assay design with the norepinephrine-equivalent framework reported in critical-care research, while emphasizing formulation consistency and practical troubleshooting.
-
Ganetespib (STA-9090) Experimental Workflows
2026-08-27
Ganetespib (STA-9090) combines nanomolar Hsp90 inhibition with a practical workflow for dose–response, client-protein, and tumor-model studies. This guide connects cancer-focused assays with secretion and cell-death readouts inspired by recent norovirus research, while clearly separating validated evidence from experimental extensions.
-
Entinostat (MS-275) Assay Workflows
2026-08-26
Build more informative Entinostat assays by separating growth arrest from true cell killing, rather than relying on a single viability endpoint. This workflow connects HDAC target engagement, cancer cell proliferation inhibition, apoptosis induction in cancer cells, and translational model selection.